Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure-Reference-Cited by-同舟云学术

Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure

Published:2009-03-03 Issue:5 Volume:104 Page:499-509
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Westermann Dirk,Riad Alexander,Richter Utz,Jäger Sebastian,Savvatis Konstantinos,Schuchardt Mirjam,Bergmann Nora,Tölle Markus,Nagorsen Dirk,Gotthardt Michael,Schultheiss Heinz-Peter,Tschöpe Carsten

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-009-0014-6.pdf

Reference48 articles.

1. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. Embo J 19:6341–6350

2. Chen X, Niroomand F, Liu Z, Zankl A, Katus HA, Jahn L, Tiefenbacher CP (2006) Expression of nitric oxide related enzymes in coronary heart disease. Basic Res Cardiol 101:346–353

3. De Keulenaer GW, Brutsaert DL (2007) Systolic and diastolic heart failure: different phenotypes of the same disease? Eur J Heart Fail 9:136–143

4. Devereux RB, Roman MJ, de Simone G, O’Grady MJ, Paranicas M, Yeh JL, Fabsitz RR, Howard BV (1997) Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the strong heart study. Circulation 96:1416–1423

5. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama T, Miwa T, Hori M (2000) Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 18:111–120

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential;International Journal of Molecular Sciences;2023-10-15

2. Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents;Pharmaceuticals;2023-10-12

3. The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies;Aging and disease;2023

4. Endothelial dysfunction: developmental mechanisms and therapeutic strategies;Research Results in Pharmacology;2022-12-22

5. Regulation of endothelial nitric oxide synthase in cardiac remodeling;International Journal of Cardiology;2022-10